Clinical guidelines generally recommend prescribing hormone therapy for a limited duration to younger women in early or mid-stage menopause who do not have complicating risks such as a history of breast cancer or cardiovascular disease.
high
guideline
Standard-risk-based approach to menopausal hormone therapy in clinical practice.